Neoplas Med Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$18M
- Investors
-
2
Neoplas Med General Information
Description
Developer of a cold plasma therapy device designed to improve the quality of life for people with acute and chronic wounds. The company offers a cold plasma jet with argon, providing effective and gentle wound therapy with precision and treatment quality without undesirable side effects and resistance development, enabling medical users to accelerate wound healing and halve treatment costs for chronic wounds.
Contact Information
Website
www.neoplas-med.euCorporate Office
- Walther-Rathenau-Straße 49a
- 17489 Greifswald
- Germany
Corporate Office
- Walther-Rathenau-Straße 49a
- 17489 Greifswald
- Germany
Neoplas Med Timeline
Neoplas Med Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 25-Nov-2024 | $18M | Completed | Generating Revenue | ||
| 2. Later Stage VC (Series B) | 24-Apr-2023 | Completed | Generating Revenue | |||
| 1. Corporate | 19-Jul-2022 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Neoplas Med Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Neoplas Med Patents
Neoplas Med Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-102023204245-A1 | Device for guiding plasma jet-generated species | Pending | 08-May-2023 | ||
| DE-102022205543-A1 | Device for guiding plasma jet-generated species | Pending | 31-May-2022 | ||
| EP-4533910-A1 | Device for guiding plasma-jet-generated species | Pending | 31-May-2022 | ||
| US-20250339703-A1 | Device for guiding plasma-jet-generated species | Pending | 31-May-2022 | ||
| WO-2023232669-A1 | Device for guiding plasma-jet-generated species | Inactive | 31-May-2022 | A61N1/44 |
Neoplas Med Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Neoplas Med Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Pegasus Tech Ventures | Corporate Venture Capital | Minority | ||
| Niterra | Corporation | Minority |
Neoplas Med Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Neoplas | Greifswald, Germany | 2005 |
Neoplas Med FAQs
-
When was Neoplas Med founded?
Neoplas Med was founded in 2009.
-
Where is Neoplas Med headquartered?
Neoplas Med is headquartered in Greifswald, Germany.
-
What is the size of Neoplas Med?
Neoplas Med has 25 total employees.
-
What industry is Neoplas Med in?
Neoplas Med’s primary industry is Other Devices and Supplies.
-
Is Neoplas Med a private or public company?
Neoplas Med is a Private company.
-
What is Neoplas Med’s current revenue?
The current revenue for Neoplas Med is .
-
How much funding has Neoplas Med raised over time?
Neoplas Med has raised $18M.
-
Who are Neoplas Med’s investors?
Pegasus Tech Ventures and Niterra have invested in Neoplas Med.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
